Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Recruiting · NCT05921253 · Registry updated 2026-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, skin disorder | Recruiting | Early phase 1 | 2026-01-26 | NCT05921253 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Oklahoma | 146 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stephenson Cancer Center | Oklahoma City | United States | 32 |
| Stephenson Cancer Center- Tulsa | Tulsa | United States | 2 |